StockGuru Spotlight on Corindus Vascular Robotics, Inc.
(Symbol: CVRS)
Help us update information on this company. Email any updates to: [email protected]
About Corindus Vascular Robotics, Inc.:
Corindus Vascular Robotics, Inc. (OTCQB: CVRS) is the global technology leader in robotic-assisted percutaneous coronary interventions (PCIs). The company’s FDA-cleared CorPath 200 System is the first medical device that offers interventional cardiologists PCI procedure control from an interventional cockpit. With the CorPath System, Corindus Vascular Robotics brings robotic precision to PCI procedures to help optimize clinical outcomes and minimize the costs associated with complications through improper stent placement. Corindus stands behind its technology with a One Stent Program
Where it is located:
309 Waverley Oaks Rd.
Suite 105
Waltham, MA
2452
United States
Key Executive Contact:
Teresa Bray
Consultant
Ninety Day Volume:
16233 (as of date of publication)
Ninety Day Dollar Volume:
$53,699
Share Information:
105883157 shares as of 2014-09-15
Corporate Information:
State Incorporated: NV
Country Incorporated: USA
Contact, Website and Social Media for Corindus Vascular Robotics, Inc.:
Shown Where Available
Website: http://www.corindus.com
Facebook: http://www.facebook.com/corindus
Twitter: http://www.twitter.com/corindusinc
LinkedIn: http://www.linkedin.com/company/corindus-vascular-robotics
Telephone: (508) 653-3335
Email: [email protected]
Investor Relations for Corindus Vascular Robotics, Inc.:
KNB Communications
http://www.knbpr.com